HD-OPM Archive
Topics › Weight, visceral & liver fat

CARDIAL-MS proposed as one multisystem metabolic disease (heart, kidney, liver, diabetes)

Louis Nervegna · Aug 04, 2025 · ♥ 2 reactions · 0 comments · original Facebook post
Weight, visceral & liver fatInsulin resistance & diabetesKidney health
AI summary & key facts

Louis shares a 2025 proposal that metabolic liver disease, diabetes, cardiovascular and kidney disorders form a single progressive syndrome rooted in dysfunctional adipose tissue and ectopic fat, and argues for early intervention beyond single risk factors.

CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease

Reference:

Paper · Diabetol Metab Syndr · 2025CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic diseasedmsjournal.biomedcentral.com

Quoted:

“Metabolic Syndrome—a constellation of insulin resistance, cardiovascular risk factors as hyperglycemia, hypertension, and dyslipidemia, and systemic metabolic dysfunction—may be driven by dysregulation of adipose tissue, which manifests as adiposopathy (pathogenic adipose tissue expansion or maldistribution), ectopic fat deposition (in the liver, muscle, pancreas, and cardiorenal systems), and altered secretion of adipokines/hepatokines. Weight gain, obesity, and/or unfavorable fat distribution create a scenario wherein the type, size, location, secretions, or even scarcity of adipocytes drive pathophysiological mechanisms leading to hepatic steatosis and steatohepatitis, type 2 diabetes, and heart and kidney disease. While recent frameworks, such as cardiovascular-kidney-metabolic syndrome, emphasize holistic staging, the central role of metabolic dysfunction-associated steatotic liver disease (MASLD) in multisystem morbidity remains underrecognized.”

#cardialmsHD #liverfatHD #pancreasfatHD #musclefatHD #ectopicfatHD #metabolicsyndromeHD #insulinresistanceHD #roytaylorHD #ckmHD #kidneysHD #cvdHD

Research cited

CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease.
CARDIAL-MS unifies metabolic liver disease, diabetes, cardiovascular, and kidney disorders as one progressive syndrome, rooted in dysfunctional adipose tissue and ectopic fat. It’s time to focus on early intervention before multiorgan damage sets in—think beyond single risk factors for true prevention. #MetabolicHealth #CARDIALMS

No photo description available.
← newer: Reliable medical knowledge does not require RCTs: smoking anolder: Calprotectin predicts ASCVD independent of traditional risk →